.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
Julphar
Teva
UBS
Federal Trade Commission
Cantor Fitzgerald
Argus Health
Mallinckrodt
Baxter

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074921

« Back to Dashboard
NDA 074921 describes ESTAZOLAM, which is a drug marketed by Watson Labs, Mayne Pharma, and Par Pharm, and is included in three NDAs. It is available from four suppliers. Additional details are available on the ESTAZOLAM profile page.

The generic ingredient in ESTAZOLAM is estazolam. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estazolam profile page.

Summary for 074921

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 074921

Ingredient-typeBenzodiazepines

Medical Subject Heading (MeSH) Categories for 074921

Suppliers and Packaging for NDA: 074921

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESTAZOLAM
estazolam
TABLET;ORAL 074921 ANDA Teva Pharmaceuticals USA, Inc. 0093-0129 0093-0129-01 100 TABLET in 1 BOTTLE (0093-0129-01)
ESTAZOLAM
estazolam
TABLET;ORAL 074921 ANDA Teva Pharmaceuticals USA, Inc. 0093-0130 0093-0130-01 100 TABLET in 1 BOTTLE (0093-0130-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Jul 10, 1997TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Jul 10, 1997TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
US Department of Justice
AstraZeneca
Medtronic
Julphar
Deloitte
Argus Health
Fish and Richardson
US Army
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot